• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS BENZ BENZODIAZEPINES; ENZYME IMMUNOASSAY, BENZODIAZEPINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS BENZ BENZODIAZEPINES; ENZYME IMMUNOASSAY, BENZODIAZEPINE Back to Search Results
Catalog Number 20737984122
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/05/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
The customer received questionable benz benzodiazepines results for one patient from cobas integra 400 plus serial number (b)(4).The urine result was negative and was reported outside the laboratory.The customer used a value of 200 for the cutoff point for the assay.As the patient was on lorazepam and the result was expected to be positive, the physician asked for confirmation testing.The customer sent the sample for confirmation testing by gc/ms and the result was 1074 ng/ml (positive).The result by gc/ms was believed to be correct.On (b)(6) 2016, the customer repeated the same sample on the cobas integra 400 plus and the result was again negative.The patient was not adversely affected.The customer refused a service visit to check the analyzer.
 
Manufacturer Narrative
Based on the information provided, a specific root cause could not be determined.As the sample in question was not available, further investigation was not possible.Additional information for further investigation was requested but was not provided.It was suspected a substance in the sample was interfering with the assay.Calibration and qc data were acceptable and did not indicate any reagent issue and confirmed the assay was performing within specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BENZ BENZODIAZEPINES
Type of Device
ENZYME IMMUNOASSAY, BENZODIAZEPINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6188420
MDR Text Key62803103
Report Number1823260-2016-02018
Device Sequence Number1
Product Code JXM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K951595
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Medical Technologist
Type of Report Initial,Followup
Report Date 01/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number20737984122
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/08/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
LORAZEPAM
-
-